|
1
|
Finn RS: Current and future treatment
strategies for patients with advanced hepatocellular carcinoma:
Role of mTOR inhibition. Liver Cancer. 1:247–256. 2012. View Article : Google Scholar
|
|
2
|
Zhang M, Wu R, Jiang J, Minuk GY and Niu
J: The presence of hepatitis B core antibody is associated with
more advanced liver disease in alcoholic patients with cirrhosis.
Alcohol. 47:553–558. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jin H, Ko YS and Kim HJ: P2Y2R-mediated
inflammasome activation is involved in tumor progression in breast
cancer cells and in radiotherapy-resistant breast cancer. Int J
Oncol. 53:1953–1966. 2018.PubMed/NCBI
|
|
4
|
Sun G, Ding X, Bi N, Wu L, Wang J, Zhang
W, Dong X, Lv N, Song Y, Zhan Q and Wang L: MiR-423-5pin brain
metastasis: Potential role in diagnostics and molecular biology.
Cell Death Dis. 9:9362018. View Article : Google Scholar
|
|
5
|
Zhang J, Mo HQ, Tian FJ, Zeng WH, Liu XR,
Ma XL, Li X, Qin S, Fan CF and Lin Y: EIF5A1 promotes trophoblast
migration and invasion via ARAF-mediated activation of the
integrin/ERK signaling pathway. Cell Death Dis. 9:9262018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mathias RA, Gopal SK and Simpson RJ:
Contribution of cells undergoing epithelial-mesenchymal transition
to the tumour microenvironment. J Proteomics. 78:545–557. 2013.
View Article : Google Scholar
|
|
7
|
Neelakantan D, Zhou H, Oliphant MUJ, Zhang
X, Simon LM, Henke DM, Shaw CA, Wu MF, Hilsenbeck SG, White LD, et
al: EMT cells increase breast cancer metastasis via paracrine GLI
activation in neighbouring tumour cells. Nat Commun. 8:157732017.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lujambio A and Lowe SW: The microcosmos of
cancer. Nature. 482:347–355. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zimmerman AL and Wu S: MicroRNAs, cancer
and cancer stem cells. Cancer Lett. 300:10–19. 2011. View Article : Google Scholar
|
|
12
|
Wang L, Wu J and Xie C: miR-92a promotes
hepatocellular carcinoma cells proliferation and invasion by FOXA2
targeting. Iran J Basic Med Sci. 20:783–790. 2017.PubMed/NCBI
|
|
13
|
Kabir TD, Ganda C, Brown R, Beveridge D,
Richardson K, Chaturvedi V, Candy P, Epis M, Wintle L, George J, et
al: A miR-7/GAS6/TYRO3 axis regulates the growth and invasiveness
of sorafenib-resistant cells in human hepatocellular carcinoma.
Hepatology. 67:216–231. 2018. View Article : Google Scholar
|
|
14
|
Cheng L, Wang H and Han S: MiR-3910
promotes the growth and migration of cancer cells in the
progression of hepatocellular carcinoma. Dig Dis Sci. 62:2812–2820.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang C, Xu Y, Cheng F, Hu Y, Yang S, Rao J
and Wang X: miR-1301 inhibits hepatocellular carcinoma cell
migration, invasion, and angiogenesis by decreasing Wnt/β-catenin
signaling through targeting BCL9. Cell Death Dis. 8:e29992017.
View Article : Google Scholar
|
|
16
|
Huo W, Du M, Pan X, Zhu X, Gao Y and Li Z:
miR-203a3p1 targets IL-24 to modulate hepatocellular carcinoma cell
growth and metastasis. FEBS Open Bio. 7:1085–1091. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ji C, Liu H, Yin Q, Li H and Gao H: miR-93
enhances hepatocellular carcinoma invasion and metastasis by EMT
via targeting PDCD4. Biotechnol Lett. 39:1621–1629. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang D, Wang JJ, Li JS and Xu QY: miR-103
functions as a tumor suppressor by directly targeting programmed
cell death 10 in NSCLC. Oncol Res. Jul 21–2017.Epub ahead of print.
View Article : Google Scholar
|
|
19
|
Zheng J, Liu Y, Qiao Y, Zhang L and Lu S:
miR-103 promotes Proliferation and metastasis by targeting KLF4 in
gastric cancer. Int J Mol Sci. 18:E9102017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen HY, Lin YM, Chung HC, Lang YD, Lin
CJ, Huang J, Wang WC, Lin FM, Chen Z, Huang HD, et al: miR-103/107
promote metastasis of colorectal cancer by targeting the metastasis
suppressors DAPK and KLF4. Cancer Res. 72:3631–3641. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xue D, Zhou C, Lu H, Xu R, Xu X and He X:
LncRNA GAS5 inhibits proliferation and progression of prostate
cancer by targeting miR-103 through AKT/mTOR signaling pathway.
Tumour Biol. 37:142016. View Article : Google Scholar
|
|
22
|
Xia W, Ni J, Zhuang J, Qian L, Wang P and
Wang J: MiR-103 regulates hepatocellular carcinoma growth by
targeting AKAP12. Int J Biochem Cell Biol. 71:1–11. 2016.
View Article : Google Scholar
|
|
23
|
Han LL, Nan HC, Tian T, Guo H, Hu TH, Wang
WJ, Ma JQ, Jiang LL, Guo QQ, Yang CC, et al: Expression and
significance of the novel tumor-suppressor gene SMG-1 in
hepatocellular carcinoma. Oncol Rep. 31:2569–2578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Hao Y, Chun A, Cheung K, Rashidi B and
Yang X: Tumor suppressor LATS1 is a negative regulator of oncogene
YAP. J Biol Chem. 283:5496–5509. 2008. View Article : Google Scholar
|
|
26
|
Zhang J, Smolen GA and Haber DA: Negative
regulation of YAP by LATS1 underscores evolutionary conservation of
the Drosophila Hippo pathway. Cancer Res. 68:2789–2794. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ling HH, Kuo CC, Lin BX, Huang YH and Lin
CW: Elevation of YAP promotes the epithelial-mesenchymal transition
and tumor aggressiveness in colorectal cancer. Exp Cell Res.
350:218–225. 2017. View Article : Google Scholar
|
|
28
|
Yuan Y, Li D, Li H, Wang L, Tian G and
Dong Y: YAP overexpression promotes the epithelial-mesenchymal
transition and chemoresistance in pancreatic cancer cells. Mol Med
Rep. 13:237–242. 2016. View Article : Google Scholar
|
|
29
|
Gong F, Ren P, Zhang Y, Jiang J and Zhang
H: MicroRNAs-491-5psuppresses cell proliferation and invasion by
inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res.
8:485–495. 2016.
|
|
30
|
Fite K and Gomez-Cambronero J:
Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 prevents
vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell
Invasion. J Biol Chem. 291:719–730. 2016. View Article : Google Scholar :
|
|
31
|
Jaca A, Govender P, Locketz M and Naidoo
R: The role of miRNA-21 and epithelial mesenchymal transition (EMT)
process in colorectal cancer. J Clin Pathol. 70:331–356. 2017.
View Article : Google Scholar
|
|
32
|
Tang O, Chen XM, Shen S, Hahn M and
Pollock CA: MiRNA-200b represses transforming growth
factor-β1-induced EMT and fibronectin expression in kidney proximal
tubular cells. Am J Physiol Renal Physiol. 304:F1266–F1273. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu J, Shan Z, Hu K, Ren F, Zhang W, Han M,
Li Y, Feng K, Lei L and Feng Y: miRNA-223 inhibits
epithelial-mesenchymal transition in gastric carcinoma cells via
Sp1. Int J Oncol. 49:325–335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Y, Hu CF, Chen J, Yan LX, Zeng YX
and Shao JY: LATS2 is de-methylated and overexpressed in
nasopharyngeal carcinoma and predicts poor prognosis. BMC Cancer.
10:5382010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang S, Li H, Wang G, Zhang T, Fu B, Ma M,
Quan Z and Chen G: Yes-associated protein (YAP) expression is
involved in epithelial-mesenchymal transition in hepatocellular
carcinoma. Clin Transl Oncol. 18:172–177. 2016. View Article : Google Scholar
|
|
36
|
Shi FP, Wang XH, Zhang HX, Shang MM, Liu
XX, Sun HM and Song YP: MiR-103 regulates the angiogenesis of
ischemic stroke rats by targeting vascular endothelial growth
factor (VEGF). Iran J Basic Med Sci. 21:318–324. 2018.PubMed/NCBI
|
|
37
|
Zhang Z, Wu S, Muhammad S, Ren Q and Sun
C: miR-103/107 promote ER stress-mediated apoptosis via targeting
the Wnt3a/β-catenin/ATF6 pathway in preadipocytes. J Lipid Res.
59:843–853. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang X, Lin Y, Peng L, Sun R, Gong X, Du J
and Zhang X: MicroRNA-103 promotes proliferation and inhibits
apoptosis in spinal osteosarcoma cells by targeting p57. Oncol Res.
26:22018. View Article : Google Scholar
|
